View all studies | Type 2 Diabetes and Obesity

Type 2 Diabetes & Obesity Clinical Trials

Type 2 diabetes and excess weight can have a significant impact on overall health and quality of life. Despite available treatments, many people continue to face challenges in managing their blood sugar levels and achieving sustainable weight loss. Ongoing research is essential to explore new treatment options that may help improve health outcomes for people living with these conditions.

We are currently planning a clinical trial for adults living with Type 2 diabetes who are overweight or living with obesity and are looking for potential participants. By registering your interest, you could help us better understand how to improve the management of Type 2 diabetes and support healthier weight outcomes in the future.

Eligible participants may:

Receive regular monitoring at trial visits and access to our medical team if needed.

Help future generations by contributing to the advancement of medical research.

Have the results of any additional investigations undertaken with the results also forwarded to their GP.

For further information and to discuss your potential eligibility with our team, please complete our online form.

Register your interest

First Name *

Last Name *

Email Address *

Phone Number (inc area code) *

Address (Town / City) *

Post Code *

Select your nearest clinic *

How did you hear about this trial? *

Are you between the ages of 18 and 75? *

Have you been diagnosed with Type 2 Diabetes for at least 6 months? *

Have you used any weight loss medications in the last 6 months? *

Register your interest in joining a clinical trial

When you register your interest with Accellacare (which is part of ICON plc), our team will review your information and connect you with studies that you may be eligible for. When we find a match, Accellacare clinical research specialists will contact you directly for further pre-screening. Please see our Privacy Policy for further details Privacy Policy.

Data Protection

ICON plc (“ICON”) is the data controller of the personal data, including health, race and ethnicity data, you choose to provide. We rely on your consent to use this information to identify potentially appropriate clinical trials for you, contact you about them, and to allow us to measure diversity of enrolment within clinical trials and support clinical trial access and diversity.

You can withdraw your consent at any time, for example by following instructions to do so in emails or SMS you receive from us, or by telling our recruitment team when speaking with them. This does not affect the lawfulness of the processing prior to your withdrawal. Additional information on how your data will be processed and how you can exercise your rights, can be found in our our Privacy Policy. Please confirm if you consent to ICON collecting and using your personal data for the above purposes. Please note that we cannot offer screening services for clinical studies without your consent to collect and use your personal data. *

I consent

Please enter the security code:

Please note: You may or may not benefit medically from taking part and you are able to opt-out at any time and do not have to give us a reason for doing so. Your GP will be informed about your participation and all medical assessments that will be carried out as part of the trial. If during screening any abnormal results are found, you and your GP will also be informed.